Greenleaf Peter

Average Profitability
37.58%
Insider Buys Quantity
1
Insider Buys Sum
$109,782.14
Insider Sells Quantity
3
Insider Sells Sum
$1.11M

Insider Activity of Greenleaf Peter

According to the SEC Form 4 filings, Greenleaf Peter, being in a position of

  1. Chief Executive Officer at Aurinia Pharmaceuticals Inc.,
    оver the last 12 months, has bought 0 shares, and sold 126981 share for $711,094,
    over all time since 2021-05-11, has bought 10250 shares for $109,782, and sold 169096 shares for $1.11M.

The largest purchase of all time was on 2021-05-11 and amounted to 10250 shares of Aurinia Pharmaceuticals Inc. for $109,782.

The largest sale of all time was on 2024-03-06 and amounted to 126981 share of Aurinia Pharmaceuticals Inc. for $711,094.

Biography of Greenleaf Peter

No biography is available at this moment.

2024-03-06SaleAurinia Pharmaceuticals Inc.
AUPH
Chief Executive Officer
126,981
0.0894%
$5.60$711,094-0.18%
2023-03-02SaleAurinia Pharmaceuticals Inc.
AUPH
Chief Executive Officer
33,047
0.0228%
$8.78$290,153+2.52%
2022-03-02SaleAurinia Pharmaceuticals Inc.
AUPH
Chief Executive Officer
9,068
0.0066%
$12.01$108,907-27.71%
2021-05-11PurchaseAurinia Pharmaceuticals Inc.
AUPH
Chief Executive Officer
10,250
0.0076%
$10.71$109,782+37.58%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.